- We will send in 10–14 business days.
/images/books/13727913/9789811405143.jpg)
- Author: Atta -Ur- Rahman
- Publisher: Bentham Science Publishers
- ISBN-10: 981140514X
- ISBN-13: 9789811405143
- Format: 17.8 x 25.4 x 1.2 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Frontiers in Clinical Drug Research - Anti-Cancer Agents (e-book) (used book) | bookbook.eu
Reviews
Description
Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers. The fifth volume of the book features reviews on biochemical inhibitors (second-generation protein kinase Inhibitors, histone deacetylase inhibitors, immune checkpoint inhibitors, EGFR Tyrosine Kinase inhibitors, non-coding RNAs), apoptosis, and physical exercise therapy for cancer patients undergoing chemotherapy. The treatment strategies in this volume cover cancers such as acute myeloid leukemia, gastrointestinal cancer, breast cancer and lung cancer.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 19d.06:02:22
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Atta -Ur- Rahman
- Publisher: Bentham Science Publishers
- ISBN-10: 981140514X
- ISBN-13: 9789811405143
- Format: 17.8 x 25.4 x 1.2 cm, softcover
- Language: English English
Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers. The fifth volume of the book features reviews on biochemical inhibitors (second-generation protein kinase Inhibitors, histone deacetylase inhibitors, immune checkpoint inhibitors, EGFR Tyrosine Kinase inhibitors, non-coding RNAs), apoptosis, and physical exercise therapy for cancer patients undergoing chemotherapy. The treatment strategies in this volume cover cancers such as acute myeloid leukemia, gastrointestinal cancer, breast cancer and lung cancer.
Reviews